Through high‐throughput proteomic analysis of HCC tissues with varying responses to anti‐PD‐1 therapy, we have identified the transcription factor YY1, associated with resistance to anti‐PD‐1 treatment. This evidence concerns the gene YY1 and hepatocellular carcinoma.